应用基因工程技术已研制出多种免疫毒素,IL-2免疫毒素是研究最为成功的例子之一,包括IL-2与绿脓杆菌外毒素的融合蛋白,IL-2与白喉毒素的融合蛋白等.这类毒素以IL-2为导向分子,IL-2受体阳性细胞为靶细胞,治疗移植排斥反应、自身免疫性疾病、T细胞淋巴瘤等疾病,在Ⅰ/Ⅱ期临床试验中已取得了较好的疗效.但是这类免疫毒素对人体均有较强的抗原性,使治疗时间和效果均受限制,为此研制了人源化的IL-2免疫毒素,能在体内外杀伤IL-2受体阳性细胞.
Various kinds of immunotoxin have been prepared with genetic engineering method.The most succcessful one among them is interleukin-2(IL-2) immunotoxin,which consists of IL-2 protein fused with pseudomonas exotoxin or diphtheria exotoxin. The IL-2 moiety in this type of immunotoxin acts as a targeting ingredient,so that to kill the target cells positive for IL-2 receptors. The IL-2 immunotoxin is being applied to treat transplantation rejections,autoimmune diseases and T cell lymphomas , etc. So far,a promising therapeutic efficiency has been achieved during the Ⅰ/Ⅱ phase clinical trials.
王露,马大龙.白细胞介素2免疫毒素研究进展[J].生物化学与生物物理进展,1995,22(5):426-428
复制生物化学与生物物理进展 ® 2025 版权所有 ICP:京ICP备05023138号-1 京公网安备 11010502031771号